Cargando…

Impaired lung function and mortality in Eastern Europe: results from multi-centre cohort study

BACKGROUND: The association between impaired lung function and mortality has been well documented in the general population of Western European countries. We assessed the risk of death associated with reduced spirometry indices among people from four Central and Eastern European countries. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarycheva, Tatyana, Capkova, Nadezda, Pająk, Andrzej, Malyutina, Sofia, Simonova, Galina, Tamosiunas, Abdonas, Bobák, Martin, Pikhart, Hynek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153198/
https://www.ncbi.nlm.nih.gov/pubmed/35641974
http://dx.doi.org/10.1186/s12931-022-02057-y
_version_ 1784717800538898432
author Sarycheva, Tatyana
Capkova, Nadezda
Pająk, Andrzej
Malyutina, Sofia
Simonova, Galina
Tamosiunas, Abdonas
Bobák, Martin
Pikhart, Hynek
author_facet Sarycheva, Tatyana
Capkova, Nadezda
Pająk, Andrzej
Malyutina, Sofia
Simonova, Galina
Tamosiunas, Abdonas
Bobák, Martin
Pikhart, Hynek
author_sort Sarycheva, Tatyana
collection PubMed
description BACKGROUND: The association between impaired lung function and mortality has been well documented in the general population of Western European countries. We assessed the risk of death associated with reduced spirometry indices among people from four Central and Eastern European countries. METHODS: This prospective population-based cohort includes men and women aged 45–69 years, residents in urban settlements in Czech Republic, Poland, Russia and Lithuania, randomly selected from population registers. The baseline survey in 2002–2005 included 36,106 persons of whom 24,993 met the inclusion criteria. Cox proportional hazards models were used to estimate the hazard ratios of mortality over 11–16 years of follow-up for mild, moderate, moderate-severe and very severe lung function impairment categories. RESULTS: After adjusting for covariates, mild (hazard ratio (HR): 1.25; 95% CI 1.15‒1.37) to severe (HR: 3.35; 95% CI 2.62‒4.27) reduction in FEV1 was associated with an increased risk of death according to degree of lung impairment, compared to people with normal lung function. The association was only slightly attenuated but remained significant after exclusion of smokers and participants with previous history of respiratory diseases. The HRs varied between countries but not statistically significant; the highest excess risk among persons with more severe impairment was seen in Poland (HR: 4.28, 95% CI 2.14‒8.56) and Lithuania (HR: 4.07, 95% CI 2.21‒7.50). CONCLUSIONS: Reduced FEV1 is an independent predictor of all-cause mortality, with risk increasing with the degree of lung function impairment and some country-specific variation between the cohorts. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12931-022-02057-y.
format Online
Article
Text
id pubmed-9153198
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91531982022-06-01 Impaired lung function and mortality in Eastern Europe: results from multi-centre cohort study Sarycheva, Tatyana Capkova, Nadezda Pająk, Andrzej Malyutina, Sofia Simonova, Galina Tamosiunas, Abdonas Bobák, Martin Pikhart, Hynek Respir Res Research BACKGROUND: The association between impaired lung function and mortality has been well documented in the general population of Western European countries. We assessed the risk of death associated with reduced spirometry indices among people from four Central and Eastern European countries. METHODS: This prospective population-based cohort includes men and women aged 45–69 years, residents in urban settlements in Czech Republic, Poland, Russia and Lithuania, randomly selected from population registers. The baseline survey in 2002–2005 included 36,106 persons of whom 24,993 met the inclusion criteria. Cox proportional hazards models were used to estimate the hazard ratios of mortality over 11–16 years of follow-up for mild, moderate, moderate-severe and very severe lung function impairment categories. RESULTS: After adjusting for covariates, mild (hazard ratio (HR): 1.25; 95% CI 1.15‒1.37) to severe (HR: 3.35; 95% CI 2.62‒4.27) reduction in FEV1 was associated with an increased risk of death according to degree of lung impairment, compared to people with normal lung function. The association was only slightly attenuated but remained significant after exclusion of smokers and participants with previous history of respiratory diseases. The HRs varied between countries but not statistically significant; the highest excess risk among persons with more severe impairment was seen in Poland (HR: 4.28, 95% CI 2.14‒8.56) and Lithuania (HR: 4.07, 95% CI 2.21‒7.50). CONCLUSIONS: Reduced FEV1 is an independent predictor of all-cause mortality, with risk increasing with the degree of lung function impairment and some country-specific variation between the cohorts. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12931-022-02057-y. BioMed Central 2022-05-31 2022 /pmc/articles/PMC9153198/ /pubmed/35641974 http://dx.doi.org/10.1186/s12931-022-02057-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Sarycheva, Tatyana
Capkova, Nadezda
Pająk, Andrzej
Malyutina, Sofia
Simonova, Galina
Tamosiunas, Abdonas
Bobák, Martin
Pikhart, Hynek
Impaired lung function and mortality in Eastern Europe: results from multi-centre cohort study
title Impaired lung function and mortality in Eastern Europe: results from multi-centre cohort study
title_full Impaired lung function and mortality in Eastern Europe: results from multi-centre cohort study
title_fullStr Impaired lung function and mortality in Eastern Europe: results from multi-centre cohort study
title_full_unstemmed Impaired lung function and mortality in Eastern Europe: results from multi-centre cohort study
title_short Impaired lung function and mortality in Eastern Europe: results from multi-centre cohort study
title_sort impaired lung function and mortality in eastern europe: results from multi-centre cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153198/
https://www.ncbi.nlm.nih.gov/pubmed/35641974
http://dx.doi.org/10.1186/s12931-022-02057-y
work_keys_str_mv AT sarychevatatyana impairedlungfunctionandmortalityineasterneuroperesultsfrommulticentrecohortstudy
AT capkovanadezda impairedlungfunctionandmortalityineasterneuroperesultsfrommulticentrecohortstudy
AT pajakandrzej impairedlungfunctionandmortalityineasterneuroperesultsfrommulticentrecohortstudy
AT malyutinasofia impairedlungfunctionandmortalityineasterneuroperesultsfrommulticentrecohortstudy
AT simonovagalina impairedlungfunctionandmortalityineasterneuroperesultsfrommulticentrecohortstudy
AT tamosiunasabdonas impairedlungfunctionandmortalityineasterneuroperesultsfrommulticentrecohortstudy
AT bobakmartin impairedlungfunctionandmortalityineasterneuroperesultsfrommulticentrecohortstudy
AT pikharthynek impairedlungfunctionandmortalityineasterneuroperesultsfrommulticentrecohortstudy